What’s more, with respect to RNA methylation, numerous vitro models and mice models have confirmed that by reducing the infiltration of M1 macrophages and Treg cells in TME, Mettl3-deficient mice displayed faster tumor growth and attenuated therapeutic efficacy of PD-1 checkpoint blockade. This evidence concerns the gene METTL3 and neoplasm.